Relmada Therapeutics Inc. (RLMD)
0.26
0.00 (0.00%)
At close: Mar 03, 2025, 3:59 PM
0.24
-5.22%
After-hours: Mar 03, 2025, 06:03 PM EST
Relmada Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 4.09M | 5.4M | 44.44M | 2.5M | 36.28M | 9.22M | 2.24M | 1.71M | 8.5M | 22.47M | 25.56M | 8.95K |
| Short-Term Investments | 92.23M | 142.93M | 167.47M | 114.6M | 80.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | 86.38K | n/a | 203.14K | 273.24K | 337.73K | 390.8K | 390.8K | n/a | n/a |
| Other Long-Term Assets | 43.13K | 34.88K | 28.29K | 25K | 190.99K | 25K | 24.79K | 21.96K | 23.55K | 10.03K | 12.1K | n/a |
| Receivables | n/a | 512.43K | 86.38K | 79.46K | n/a | 247.08K | 72.1K | 291.92K | n/a | n/a | n/a | n/a |
| Inventory | n/a | 4.04M | 11.3M | 903.2K | n/a | 459K | 426.9K | 472.5K | 534.8K | 1.35M | n/a | 6.41K |
| Other Current Assets | 1.19M | 4.04M | 11.3M | 903.19K | 497K | 520.75K | 426.92K | 472.49K | 809.94K | 2.21M | 178.16K | 3K |
| Total Current Assets | 97.51M | 152.87M | 223.3M | 118.07M | 116.94M | 9.98M | 2.74M | 2.47M | 9.3M | 23.97M | 25.74M | 18.35K |
| Property-Plant & Equipment | n/a | n/a | n/a | 1.26K | 5.01K | 7.21K | 12.08K | 2.31K | 531.35K | 23.91K | 9.84K | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 43.13K | 34.88K | 28.29K | 112.64K | 196K | 235.35K | 310.11K | 362.01K | 945.7K | 424.74K | 21.94K | n/a |
| Total Assets | 97.55M | 152.91M | 223.33M | 118.19M | 117.14M | 10.22M | 3.05M | 2.84M | 10.24M | 24.39M | 25.76M | 18.35K |
| Account Payables | 3.51M | 5.26M | 11.19M | 8.35M | 522.66K | 924.36K | 765.44K | 529.56K | 1.26M | 835.28K | 746.1K | 7K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 1.32M | 659.5K | 394.6K | 634.9K | 482.2K | 382.02K | n/a |
| Short-Term Debt | n/a | n/a | n/a | n/a | 110.25K | 364.2K | 285.17K | 276.67K | 273.67K | 263.75K | 58.36K | n/a |
| Other Current Liabilities | 8.69M | 7.21M | 3.87M | 4.26M | 824.94K | 1.32M | 4.85M | 570.41K | 1.53M | 14.48M | 25.97M | n/a |
| Total Current Liabilities | 12.19M | 12.47M | 15.06M | 12.6M | 1.46M | 2.61M | 5.9M | 1.38M | 3.06M | 15.58M | 26.77M | 7K |
| Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | 2.66M | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 140.91K | n/a | 100K | n/a |
| Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 2.66M | n/a | 140.91K | n/a | 100K | n/a |
| Total Liabilities | 12.19M | 12.47M | 15.06M | 12.6M | 1.46M | 2.61M | 8.56M | 1.38M | 3.2M | 15.58M | 26.87M | 7K |
| Total Debt | n/a | n/a | n/a | n/a | 110.25K | 364.2K | 2.94M | 276.67K | 273.67K | 263.75K | 58.36K | n/a |
| Common Stock | 30.1K | 30.1K | 27.74K | 16.33K | 14.46K | 9.74K | 3.14K | 12.53K | 12.04K | 10.78K | 40.29K | 23.5K |
| Retained Earnings | -560.9M | -462.11M | -305.07M | -179.32M | -119.86M | -111.66M | -94.34M | -85.38M | -79.1M | -76.12M | -55.32M | -12.14K |
| Comprehensive Income | n/a | -0.00 | n/a | 0.00 | -0.00 | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a |
| Shareholders Equity | 85.36M | 140.44M | 208.26M | 105.58M | 115.68M | 7.61M | -5.51M | 1.46M | 7.04M | 8.81M | -55.28M | 11.36K |
| Total Investments | 92.23M | 142.93M | 167.47M | 114.6M | 80.16M | 203.14K | 273.24K | 337.73K | 390.8K | 390.8K | n/a | n/a |